Corcept Therapeutics Incorporated (CORT) — Free Cash Flow Generation Index
Corcept Therapeutics Incorporated (CORT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $38.40 Million represents 1% of operating cash flow ($38.45 Million). See working capital position of Corcept Therapeutics Incorporated to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Corcept Therapeutics Incorporated Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Corcept Therapeutics Incorporated across 11 annual periods. Explore Corcept Therapeutics Incorporated debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year Free Cash Flow Generation Index for Corcept Therapeutics Incorporated. For the full company profile including market capitalisation, see CORT market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $141.78 Million | $142.00 Million | $211.00K | ▲ +1.0% |
| 2024 | 0.99x | $195.90 Million | $198.07 Million | $2.17 Million | ▼ -1.0% |
| 2023 | 1.00x | $126.90 Million | $127.04 Million | $139.00K | ▲ +0.2% |
| 2022 | 1.00x | $119.91 Million | $120.32 Million | $413.00K | ▼ -0.1% |
| 2021 | 1.00x | $167.42 Million | $167.89 Million | $469.00K | ▲ +0.5% |
| 2020 | 0.99x | $150.73 Million | $151.97 Million | $1.24 Million | ▼ 0.0% |
| 2019 | 0.99x | $135.03 Million | $136.12 Million | $1.09 Million | ▼ -0.5% |
| 2018 | 1.00x | $115.37 Million | $115.67 Million | $298.00K | ▲ +0.4% |
| 2017 | 0.99x | $60.52 Million | $60.94 Million | $419.00K | ▲ +0.4% |
| 2016 | 0.99x | $18.20 Million | $18.39 Million | $194.00K | ▼ -0.5% |
| 2015 | 0.99x | $3.11 Million | $3.13 Million | $17.00K | — |